Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01238250 · ClinicalTrials.gov registry record
Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
A clinical trial of 16P11.2 Deletion Syndrome and ADNP, sponsored by Simons Searchlight.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 2
- Study locations
NCT01238250 is a study of 16P11.2 Deletion Syndrome and ADNP that is actively recruiting participants, run by Simons Searchlight. The registered enrollment target is 100,000 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01238250, a study of 16P11.2 Deletion Syndrome and ADNP, is actively recruiting participants, sponsored by Simons Searchlight.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.
Conditions Studied
Study Locations (2)
Massachusetts
- Boston Children's Hospital - Boston
Pennsylvania
- Geisinger Health System - Lewisburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2010-10 |
| Est. Completion | 2050-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01238250
The ClinicalTrials.gov registry entry for NCT01238250 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Simons Searchlight, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with 16P11.2 Deletion Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01238250 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01238250 about?
NCT01238250 is a clinical study titled "Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight". Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who h...
What is the current status of trial NCT01238250?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2010-10. Estimated completion is 2050-10.
What conditions does trial NCT01238250 study?
This clinical trial studies the following conditions: 16P11.2 Deletion Syndrome, ADNP, 16p11.2 Duplications, 1Q21.1 Deletion, 1Q21.1 Microduplication Syndrome (Disorder).
Who is sponsoring clinical trial NCT01238250?
This trial is sponsored by Simons Searchlight, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01238250 being conducted?
This trial has 2 study locations across Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for 16P11.2 Deletion Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.